semaglutide nature medicine Two-year effects of in adults with overweight or obesity: the STEP 5 trial BELIEVE it or not… this
Description
Ships daily from Australia.
| 154 comments on LinkedIn
Tennis legend Serena Williams is all set to return to competition after a four-year absence
GLP-1 (glucagon-like peptide-1) receptor agonists originally developed for metabolic health are showing remarkable promise in the treatment of alcohol use disorder
Among the mechanisms, our research group and others have demonstrated that the gut microbiota fermentation (i.e., bacterial digestion of specific compounds) of specific prebiotics or other non-digestible carbohydrates is associated with the secretion of enteroendocrine peptides, such as the glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), produced by L-cells
